Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Buti

Showing results (111-120 of 386) with videos related to

Pageof 39
Sort By:
Nature Reviews. Gastroenterology & Hepatology|June 23, 2022
Ten steps to eliminating hepatitis C in hospitalsJosé Luis Calleja, Antonio Aguilera, Maria Buti, et al.
Journal of Clinical Microbiology|February 6, 2015
An OPTIMIZE study retrospective analysis for management of telaprevir-treated hepatitis C virus (HCV)-infected patients by use of the Abbott RealTime HCV RNA assayChristoph Sarrazin, Inge Dierynck, Gavin Cloherty, et al.
Antiviral Research|March 26, 2013
A comparative study of ultra-deep pyrosequencing and cloning to quantitatively analyze the viral quasispecies using hepatitis B virus infection as a modelClara Ramírez, Josep Gregori, Maria Buti, et al.
Journal of Hepatology|July 13, 2004
Sporadic cases of acute autochthonous hepatitis E in SpainMaria Buti, Pilar Clemente-Casares, Rosend Jardi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 2, 2021
The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four european countriesFrancesco S Mennini, Andrea Marcellusi, Sarah Robbins Scott, et al.
Expert Review of Molecular Diagnostics|April 21, 2021
Next-generation sequencing for the diagnosis of hepatitis B: current status and future prospectsSelene Garcia-Garcia, Maria Francesca Cortese, Francisco Rodríguez-Algarra, et al.
Transplantation|August 7, 2016
The Optimal Timing of Hepatitis C Therapy in Transplant Eligible Patients With Child B and C Cirrhosis: A Cost-Effectiveness AnalysisElliot B Tapper, Michael S Hughes, Maria Buti, et al.
Journal of Hepatology|November 18, 2005
Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremiaStefan Zeuzem, Maria Buti, Peter Ferenci, et al.
Alimentary Pharmacology & Therapeutics|November 14, 2019
Long-term clinical outcomes in patients with chronic hepatitis delta: the role of persistent viraemiaAdriana Palom, Sergio Rodríguez-Tajes, Carmen A Navascués, et al.
Journal of Hepatology|July 7, 2012
Hepatitis B virus and human immunodeficiency virus drugs in pregnancy: findings from the Antiretroviral Pregnancy RegistryRobert S Brown, Elizabeth C Verna, Marcus R Pereira, et al.
Pageof 39

Showing results (111-120 of 386) with videos related to

Sort By:
Pageof 39
Nature Reviews. Gastroenterology & Hepatology|June 23, 2022
Ten steps to eliminating hepatitis C in hospitalsJosé Luis Calleja, Antonio Aguilera, Maria Buti, et al.
Journal of Clinical Microbiology|February 6, 2015
An OPTIMIZE study retrospective analysis for management of telaprevir-treated hepatitis C virus (HCV)-infected patients by use of the Abbott RealTime HCV RNA assayChristoph Sarrazin, Inge Dierynck, Gavin Cloherty, et al.
Antiviral Research|March 26, 2013
A comparative study of ultra-deep pyrosequencing and cloning to quantitatively analyze the viral quasispecies using hepatitis B virus infection as a modelClara Ramírez, Josep Gregori, Maria Buti, et al.
Journal of Hepatology|July 13, 2004
Sporadic cases of acute autochthonous hepatitis E in SpainMaria Buti, Pilar Clemente-Casares, Rosend Jardi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 2, 2021
The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four european countriesFrancesco S Mennini, Andrea Marcellusi, Sarah Robbins Scott, et al.
Expert Review of Molecular Diagnostics|April 21, 2021
Next-generation sequencing for the diagnosis of hepatitis B: current status and future prospectsSelene Garcia-Garcia, Maria Francesca Cortese, Francisco Rodríguez-Algarra, et al.
Transplantation|August 7, 2016
The Optimal Timing of Hepatitis C Therapy in Transplant Eligible Patients With Child B and C Cirrhosis: A Cost-Effectiveness AnalysisElliot B Tapper, Michael S Hughes, Maria Buti, et al.
Journal of Hepatology|November 18, 2005
Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremiaStefan Zeuzem, Maria Buti, Peter Ferenci, et al.
Alimentary Pharmacology & Therapeutics|November 14, 2019
Long-term clinical outcomes in patients with chronic hepatitis delta: the role of persistent viraemiaAdriana Palom, Sergio Rodríguez-Tajes, Carmen A Navascués, et al.
Journal of Hepatology|July 7, 2012
Hepatitis B virus and human immunodeficiency virus drugs in pregnancy: findings from the Antiretroviral Pregnancy RegistryRobert S Brown, Elizabeth C Verna, Marcus R Pereira, et al.
Pageof 39